Swiss National Bank Has $14.86 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Swiss National Bank reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 38.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 417,600 shares of the medical instruments supplier's stock after selling 263,701 shares during the period. Swiss National Bank owned about 0.20% of DENTSPLY SIRONA worth $14,862,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its holdings in shares of DENTSPLY SIRONA by 5.3% during the fourth quarter. Russell Investments Group Ltd. now owns 900,306 shares of the medical instruments supplier's stock valued at $32,042,000 after buying an additional 45,711 shares in the last quarter. Headlands Technologies LLC acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at approximately $30,000. Sonen Capital LLC acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $259,000. GAMMA Investing LLC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at $55,000. Finally, Parkside Financial Bank & Trust boosted its holdings in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier's stock worth $42,000 after purchasing an additional 292 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on XRAY. The Goldman Sachs Group reduced their price target on DENTSPLY SIRONA from $34.00 to $30.00 and set a "neutral" rating for the company in a research report on Monday, May 6th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a "neutral" rating on the stock in a report on Friday, May 3rd. Leerink Partnrs reissued an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a "buy" rating for the company in a report on Friday, May 3rd. Finally, SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an "outperform" rating and a $42.00 target price for the company. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.22.

DENTSPLY SIRONA Price Performance

XRAY stock traded down $0.31 during trading on Friday, hitting $27.89. The company had a trading volume of 7,071,708 shares, compared to its average volume of 3,055,453. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The company has a fifty day moving average price of $31.60 and a two-hundred day moving average price of $32.57. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The company has a market cap of $5.79 billion, a P/E ratio of -63.38, a P/E/G ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to analysts' expectations of $969.45 million. During the same quarter in the previous year, the company posted $0.39 earnings per share. DENTSPLY SIRONA's quarterly revenue was down 2.6% compared to the same quarter last year. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.29%. The ex-dividend date was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.